Drug Type Universal CAR-T |
Synonyms HY 032, HY032 |
Target |
Mechanism CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | Juventas Cell Therapy Ltd.Startup | 08 Nov 2023 |